Stocks and Investing
Stocks and Investing
Tue, January 19, 2021
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
Mon, January 18, 2021
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
Fri, January 15, 2021
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
Swayampakula Ramakanth Maintained (BCYC) at Strong Buy with Increased Target to $31 on, Jan 15th, 2021
Swayampakula Ramakanth of HC Wainwright & Co., Maintained "Bicycle Therapeutics plc" (BCYC) at Strong Buy with Increased Target from $28 to $31 on, Jan 15th, 2021.
Swayampakula has made no other calls on BCYC in the last 4 months.
There is 1 other peer that has a rating on BCYC. Out of the 1 peers that are also analyzing BCYC, 0 agree with Swayampakula's Rating of Hold.
This is the rating of the analyst that currently disagrees with Swayampakula
- Alethia Young of "Cantor Fitzgerald" Initiated at Buy and Held Target at $30 on, Monday, October 12th, 2020
Contributing Sources